Core Viewpoint - A class action securities lawsuit has been filed against Compass Group Diversified Holdings, LLC due to alleged securities fraud affecting investors between February 24, 2022, and May 7, 2025 [1][2] Group 1: Allegations and Impact - The lawsuit claims that Compass Diversified failed to disclose effective internal controls over financial reporting and critical information regarding its subsidiary, Lugano Holding, Inc., which had undisclosed financing arrangements and irregularities in sales, cost of sales, inventory, and accounts receivable [2] - On May 7, 2025, Compass announced that its financial statements for fiscal 2024 could no longer be relied upon due to an internal investigation into Lugano, leading to a significant drop in stock price from $17.25 per share to $6.55 per share within one day [2] Group 2: Legal Proceedings - Investors who suffered losses during the relevant time frame have until July 8, 2025, to request to be appointed as lead plaintiff in the class action lawsuit [3] - Class members may be entitled to compensation without any out-of-pocket costs or fees [3] Group 3: Firm Background - Levi & Korsinsky, LLP has a strong track record in securities litigation, having secured hundreds of millions of dollars for shareholders over the past 20 years and consistently ranking among the top securities litigation firms in the United States [4]

Core Insights - Opus Genetics, Inc. is a clinical-stage biopharmaceutical company focused on developing gene therapies for inherited retinal diseases and small molecule therapies for other ophthalmic disorders [1][3] - The company granted equity awards to two new non-executive employees as an inducement for employment, consisting of stock options and restricted stock units (RSUs) [1][2] Equity Awards Details - The equity awards include stock options for 240,000 shares and 150,000 RSUs, with the stock options having an exercise price of $0.94, equal to the closing price on the grant date [2] - Stock options vest over four years, with 25% vesting on the one-year anniversary and the remaining 75% vesting quarterly thereafter; RSUs vest in four equal installments on each anniversary of the grant date [2] Company Pipeline - Opus Genetics is developing AAV-based gene therapies targeting inherited retinal diseases such as Leber congenital amaurosis (LCA), bestrophinopathy, and retinitis pigmentosa [3] - The lead candidate, OPGx-LCA5, is in a Phase 1/2 trial for LCA5-related mutations and has shown promising early results [3] - Additional programs include OPGx-BEST1 for BEST1-related retinal degeneration and a Phase 3-ready small molecule therapy for diabetic retinopathy, developed under a Special Protocol Assessment with the FDA [3] - The company is also advancing Phentolamine Ophthalmic Solution 0.75%, which is approved for one indication and is being studied in two Phase 3 programs for presbyopia and dim light vision disturbances [3]

Dakota Gold Announces Date for Webcast Conference Call to Review the Initial Assessment with Cash Flow for Richmond HillJuly 03, 2025 4:30 PM EDT | Source: Dakota Gold Corp.Lead, South Dakota--(Newsfile Corp. - July 3, 2025) - Dakota Gold Corp. (NYSE American: DC) ("Dakota Gold" or the "Company") is pleased to announce the expected release of the S-K 1300 Initial Assessment Technical Report with economic analysis ("S-K 1300 Initial Assessment with Cash Flow", "IACF" or "Report") for the Richmo ...

NORWALK, Conn., July 3, 2025 /PRNewswire/ -- Emeren Group Ltd ("Emeren" or the "Company") (www.emeren.com) (NYSE: SOL), a leading global solar project developer, owner, and operator, today announced a leadership transition within its North America operations. Mr. Cameron "Mac" Moore, Executive Vice President - North America, has departed the Company, and Mr. M. Jahangir Alam has been appointed as his successor, effective immediately.About M. Jahangir AlamM. Jahangir Alam is a seasoned leader in the North Am ...

NEW YORK, July 03, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in 3D Systems Corporation ("3D Systems Corporation" or the "Company") (NYSE: DDD) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of 3D Systems Corporation investors who were adversely affected by alleged securities fraud between August 13, 2024 and May 12, 2025. Follow the link below to get more information and be contacted by a member of our team: https://zlk.com/pslra ...

NEW YORK, July 03, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Organon & Co. ("Organon" or the "Company") (NYSE: OGN) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Organon investors who were adversely affected by alleged securities fraud between October 31, 2024 and April 30, 2025. Follow the link below to get more information and be contacted by a member of our team: https://zlk.com/pslra-1/organon-co-lawsuit-submission-for ...

● 本报记者熊彦莎 研究符合条件的资产管理公司(不含金融资产管理公司、基金管理公司、地方资产管理公司)开展资产支 持证券跨境转让业务，在具备条件的自由贸易试验区探索融资租赁资产跨境转让并试点以人民币结算。 根据自由贸易试验区全面对接国际高标准经贸规则推进高水平制度型开放试点措施复制推广任务表，在 加快服务贸易扩大开放方面，通知提出，深化金融科技发展和国际合作，便利金融机构开展跨境资产管 理，为境外设立的基金产品提供境内投资管理、估值核算等服务。有序推进数字人民币试点，支持具备 条件的自由贸易试验区探索数字人民币在贸易领域的应用场景。 优化跨国公司跨境资金集中运营管理政策，支持跨国公司设立资金管理中心，在具备条件的自由贸易试 验区完善资金池安排。支持再保险行业发展，推进再保险国际化进程。 在具备条件的自由贸易试验区提升自由贸易账户系统功能，优化账户规则，实现资金在自由贸易试验区 与境外间依法有序自由流动。 中国政府网7月3日消息，国务院日前印发的《关于做好自由贸易试验区全面对接国际高标准经贸规则推 进高水平制度型开放试点措施复制推广工作的通知》3日对外发布。 通知指出，2023年11月，国务院印发《全面对接国际 ...

NEW YORK, July 03, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Bitfarms Ltd. ("Bitfarms Ltd." or the "Company") (NASDAQ: BITF) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Bitfarms Ltd. investors who were adversely affected by alleged securities fraud between March 21, 2023 and December 9, 2024. Follow the link below to get more information and be contacted by a member of our team: https://zlk.com/pslra-1/bitfarms-ltd-lawsu ...

NEW YORK, July 03, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in DoubleVerify Holdings, Inc. ("DoubleVerify Holdings, Inc." or the "Company") (NYSE: DV) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of DoubleVerify Holdings, Inc. investors who were adversely affected by alleged securities fraud between November 10, 2023 and February 27, 2025. Follow the link below to get more information and be contacted by a member of our team: ...

NEW YORK, July 03, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Reckitt Benckiser Group plc ("Reckitt Benckiser Group plc" or the "Company") (OTC PINK: RBGLY) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Reckitt Benckiser Group plc investors who were adversely affected by alleged securities fraud between January 13, 2021 and July 28, 2024. Follow the link below to get more information and be contacted by a member of our team ...